28 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Clementia Pharmaceuticals, Inc. Funding History

Since Clementia Pharmaceuticals, Inc. was founded in 2011, it has participated in 5 rounds of funding. In total Clementia Pharmaceuticals, Inc. has raised $102.5M. Clementia Pharmaceuticals, Inc.'s last funding round was on Aug 2017 for a total of $0.

Clementia Pharmaceuticals, Inc. Funding Rounds

Unlock 2 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

IPO
Aug 2017
--
1
Fonds de solidarité
Series C
Aug 2017
$10M
1
Fonds de solidarité
Equity
Jun 2015
$60M
5
New Enterprise Associates,  RA Capital Management,  Rock Springs Capital,  EcoR1 Capital,  OrbiMed Advisors
Series A
Jan 2015
$10M
2
OrbiMed Advisors,  BDC Venture Capital
Series A
Jan 2014
$22.5M
2
OrbiMed Advisors,  BDC Venture Capital

Total Funding: $102.5M

Clementia Pharmaceuticals, Inc. Investors

Unlock 4 more investors →

INVESTOR

ROUND

FUNDING DATE

Fonds de solidarité
IPO, Series C
Aug 2017
New Enterprise Associates
Equity
Jun 2015
RA Capital Management
Equity
Jun 2015
Rock Springs Capital
Equity
Jun 2015
EcoR1 Capital
Equity
Jun 2015

Total Investors: 7

Clementia Pharmaceuticals, Inc. has 7 investors, including Fonds de solidarité, New Enterprise Associates and RA Capital Management. The latest investment occurred in Aug 2017.